Occult cancer in specimens of reduction mammaplasty aimed at symmetrization. A multicentric study of 2718 patients - Université de Rennes Access content directly
Journal Articles The Breast Year : 2015

Occult cancer in specimens of reduction mammaplasty aimed at symmetrization. A multicentric study of 2718 patients

T. Sorin
  • Function : Author
J. P. Fyad
  • Function : Author
Etienne Delay
P. Rouanet
F. Rimareix
  • Function : Author
J. L. Houpeau
  • Function : Author
J. M. Classe
  • Function : Author
I. Garrido
  • Function : Author
C. Tunon de Lara
  • Function : Author
G. Houvenaeghel
K. B. Clough
  • Function : Author
I. Sarfati
  • Function : Author
N. Leymarie
  • Function : Author
M. Trudel
  • Function : Author
J. Salleron
  • Function : Author
Francis Guillemin
G. Oldrini
  • Function : Author
M. Brix
  • Function : Author
G. Dolivet
  • Function : Author
E. Simon
  • Function : Author
J. L. Verhaeghe
  • Function : Author
F. Marchal
  • Function : Author

Abstract

Women who have undergone surgical treatment for breast cancer often benefit from a contralateral reduction mammaplasty (CRM) aimed at symmetrization of the contralateral breast unaffected by the initial cancer. In our 7-year multicentric study (12 centers) of 2718 patients, incidence of CRM cancers (CRMc) was 1.47% (n = 40) [95% CI 1.05%-2.00%]. The CRMc group had significantly more initial mammary cancers of invasive lobular carcinoma (ILC, 22.5% vs 12.0%) and ductal carcinoma in situ (DCIS, 35.0% vs 21.6%) types than the healthy CRM group (p = 0.017). 35.0% (n = 14) of patients had en bloc resection; 25.0% (n = 10) of surgical specimens were correctly oriented. En bloc resection and orientation of surgical specimens enable precise pinpointing of the CRMc. A salvage lumpectomy may be proposed as an option when margins are invaded. The histological distribution of the 40 CRMc (mean size 12.7 mm) was carcinoma in situ (CIS) 70%, ILC 12.5%, invasive ductal carcinoma (IDC) 12.5% and tubular carcinoma (TC) 5.0%.
No file

Dates and versions

hal-01146930 , version 1 (29-04-2015)

Identifiers

Cite

T. Sorin, J. P. Fyad, Etienne Delay, P. Rouanet, F. Rimareix, et al.. Occult cancer in specimens of reduction mammaplasty aimed at symmetrization. A multicentric study of 2718 patients. The Breast, 2015, 24 (3), pp.272-277. ⟨10.1016/j.breast.2015.02.033⟩. ⟨hal-01146930⟩
23 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More